Summary.
A series of substituted heterocyclic systems were prepared from N 1-[4-(2-thienylmethylene)phenyl]-5-chloro-2-methoxybenzamide, which was prepared from the corresponding 5-chloroanisic acid (2-methoxy-4-chlorobenzoic acid) as starting material. Condensation of the thienylmethylene derivative with guanidine hydrochloride, urea, or thiourea afforded the aminopyrimidine, pyrimidinone, and thioxopyrimidine derivatives. The latter was condensed with chloroacetic acid to yield a thiazolopyrimidine, which was condensed with 2-thiophenealdehyde to yield the arylmethylene derivative, however, it was also prepared directly from thiopyrimidine by the action of chloroacetic acid, 2-thiophenealdehyde, and anhydrous sodium acetate. Treating of the thienylmethylene derivative with phenylhydrazine or hydrazine hydrate in dioxane afforded N-phenylpyrazoline and a pyrazoline, which was reacted with acetyl chloride in dioxane affording the N-acetyl analogue. The thienylmethylene derivative was reacted with malononitrile or ethyl cyanoacetate in the presence of ammonium acetate to yield the corresponding cyanoaminopyridine and cyanopyrimidone derivatives. Also, it was reacted with hydroxylamine hydrochloride in pyridine to give the oxime derivative, which was cyclized with acetic anhydride. On the other hand, condensation of the thienylmethylene derivative with ethyl cyanoacetate in the presence of sodium ethoxide or cyanothioacetamide gave the cyanopyrane and pyridine thione derivative, which was treated with ethyl chloroacetate affording the ethyl carboxylate derivative. The pharmacological screening showed that many of these compounds have good anti-arrhythmic activity and low toxicity.
Similar content being viewed by others
References
NA Abdel-Latif (2005) Scientia Pharmaceutica 74 193
AE Amr NA Abdel-Latif MM Abdalla (2006) Acta Pharm 56 203 Occurrence Handle1:CAS:528:DC%2BD28XltValsLw%3D
AE Amr NA Abdel-Latif MM Abdalla (2006) Bioorg Med Chem 14 273 Occurrence Handle10.1016/j.bmc.2005.08.023 Occurrence Handle1:CAS:528:DC%2BD2MXht1egsLvI
AE Amr (2005) Z Naturforsch 60b 990
AE Amr HH Sayed MM Abdulla (2005) Arch Pharm Chem Life Sci 338 433 Occurrence Handle10.1002/ardp.200500982 Occurrence Handle1:CAS:528:DC%2BD2MXhtV2hu73J
MH Abo-Ghalia AE Amr (2004) Amino Acids 26 283 Occurrence Handle10.1007/s00726-003-0042-8 Occurrence Handle1:CAS:528:DC%2BD2cXkvF2ms74%3D
AG Hammam AFM Fahmy AE Amr AM Mohamed (2003) Ind J Chem 42B 1985 Occurrence Handle1:CAS:528:DC%2BD3sXms1Wgt7c%3D
AM Bunker JJ Edmund KA Berryman DN Walker MA Flynn KM Welch AM Doherty (1996) Bioorg Med Chem Lett 6 1061 Occurrence Handle10.1016/0960-894X(96)00170-9 Occurrence Handle1:CAS:528:DyaK28XjtFCksbY%3D
X Yao-Chang KW Johnson LA Phebus M Cohen DL Nelson K Schenk CD Walker JE Fritz SW Kolder NE Letourneau RE Murff JM Zgombick DO Calligaro JE Audia JM Schaust (2001) J Med Chem 44 4031 Occurrence Handle10.1021/jm0155190 Occurrence Handle1:CAS:528:DC%2BD3MXns1Ohs74%3D
C Bailly L Dassonneville P Colson C Houssier K Fukasawa S Nishimura T Yoshinari (1999) Cancer Res 59 2853 Occurrence Handle1:CAS:528:DyaK1MXktVOku7o%3D
AH van Hattum HM Pinedo HNM Schluper CAM Erkelens A Tongo E Boven (2002) Biochem Pharm 64 1267 Occurrence Handle10.1016/S0006-2952(02)01297-2 Occurrence Handle1:CAS:528:DC%2BD38XntVWqtrk%3D
L He X Chang TC Chou N Savaraj CC Cheng (2003) Eur J Med Chem 38 101 Occurrence Handle10.1016/S0223-5234(02)01420-4 Occurrence Handle1:CAS:528:DC%2BD3sXht1yqtrk%3D
H Sugiyama F Yokokawa T Aoyama T Shiori (2001) Tetrahedron Lett 42 7277 Occurrence Handle10.1016/S0040-4039(01)01492-7 Occurrence Handle1:CAS:528:DC%2BD3MXmvFCjsrw%3D
CG Yang G Liu B Jiany (2002) J Org Chem 67 9392 Occurrence Handle10.1021/jo026450m Occurrence Handle1:CAS:528:DC%2BD38XovFSku7s%3D
Y Min M Borgne F Pagnez G Baut P Pape (2003) Eur J Med Chem 38 75 Occurrence Handle10.1016/S0223-5234(02)00005-3 Occurrence Handle1:CAS:528:DC%2BD3sXht1yqtrs%3D
AE Amr MI Hegab AA Ibrahim MM Abdalah (2003) Monatsh Chem 134 1395 Occurrence Handle1:CAS:528:DC%2BD3sXnvVWrurs%3D
AE Amr MM Abdulla (2002) Ind J Heterocycl Chem 12 129 Occurrence Handle1:CAS:528:DC%2BD3sXkvVWiug%3D%3D
A Attia OI Abdel-Salam MH Abou-Ghalia AE Amr (1995) Egypt J Chem 38 543 Occurrence Handle1:CAS:528:DyaK28Xitl2jt7o%3D
A Attia OI Abdel-Salam AE Amr (2000) Egypt J Chem 43 297 Occurrence Handle1:CAS:528:DC%2BD3cXptFSnsr4%3D
A Attia OI Abdel-Salam AE Amr (1997) Egypt J Chem 40 317 Occurrence Handle1:CAS:528:DyaK2sXmslCrtrk%3D
KF Austen WE Brocklehurst (1961) J Exp Med 113 521 Occurrence Handle10.1084/jem.113.3.521 Occurrence Handle1:CAS:528:DyaF3MXotF2qtA%3D%3D
MJA Walker MJ Curtius DJ Hearse RWF Campbell MJ Jams DM Yellon SM Coker JB Harness DWG Harron AJ Miggins DG Julian MJ Lab AS Manning BJ Northover JR Parratt RA Riemrsma E Riva DC Russell DJ Sheridan E Winslow B Woodward (1988) Cardiovasc Res 22 447 Occurrence Handle1:STN:280:DyaL1Mzgtl2kug%3D%3D Occurrence Handle10.1093/cvr/22.7.447
A Vaille AM Scotto di Tella J Maldonado P Vanelle (1992) Meth Find Exp Clin Pharmacol 14 183 Occurrence Handle1:CAS:528:DyaK38XltVentLg%3D
C Bazzani S Genedani S Tugliavini A Bertolini (1989) J Pharm Pharmacol 41 651 Occurrence Handle1:CAS:528:DyaL1MXmt1Gjur4%3D
FLUHR DeClerk (1993) J Cardiovasc Pharmacol 22 120
E Winslow (1980) Br J Pharmac 71 615 Occurrence Handle1:CAS:528:DyaL3MXhvVGhtbo%3D
E Winslow (1981) J Cardiovasc Pharmac 3 87 Occurrence Handle1:STN:280:DyaL3M%2FntlGrtw%3D%3D Occurrence Handle10.1097/00005344-198101000-00008
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdulla, M. Synthesis and Reactions of Some Substituted Heterocyclic Systems as Anti-arrhythmic Agents. Monatsh. Chem. 139, 69–76 (2008). https://doi.org/10.1007/s00706-007-0739-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-007-0739-6